REFERENCES
- Stefanini M, Pisciotta AV: Rate of disappearance of prothrombin from the circulation. Science 111: 364, 1950
- Schneider CL: “Fibrin embolism” (disseminated intravascular coagulation) with defibrination as one of the end results during placenta abruptio. Surg Gynecol Obstet 92: 27–34, 1951
- Stefanini M: Fibrinolysis and “fibrinolytic purpura.” Blood 7: 1044–1046, 1952
- Stefanini M, Marin HM: Diffuse intravascular clotting: Its pathogenesis, clinical importance and relation to hemostatic breakdown. Proceedings of the seventh congress of the International Society of Hematology. Rome, Italy, Il Pensiero Scientifico, 1958, pp 139–145
- Karaca M, Stefanini M, Mele RH, et al: Fibrinolysis. VIII. Comparative study in vitro of the effects of various proteolytic agents on the blood clotting mechanism of human plasma. J Lab Clin Med 60: 117–124, 1962
- McKay DG: Disseminated Intravascular Coagulation: An Intermediary Mechanism of Disease. New York, Medical Department, Harper & Row, Publishers, Inc, 1965
- Seaman AJ: Recognition of intravascular clotting. Arch Intern Med 125: 1016–1021, 1970
- Breen FA Jr, Tullis JL: Ethanol gelation: A rapid screening test for intravascular coagulation. Ann In tern Med 69: 1197–1206, 1968
- Merskey C, Lalezari P, Johnson AJ: A rapid, simple, sensitive method for measuring fibrinolytic split products in human serum. Proc Soc Exp Biol Med 131: 871–875, 1969
- Merskey C, Kleiner GJ, Johnson AJ: Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment. Blood 28: 1–18, 1966
- Ferreira HC, Murat LG: An immunological method for demonstrating fibrin degradation products in serum and its use in the diagnosis of fibrinolytic states. Br J Haematol 9: 299–310, 1963
- Hirsch J, Fletcher AP, Sherry S: Effect of fibrin and fibrinogen proteolysis products on clot physical properties. Am J Physiol 209: 415–424, 1965
- Nussenzweig V, Seligmann M, Graber P: [The degradation products of human fibrinogen by plasmin. II. Immunological study: Existence of native antifibrinogen antibodies possessing different specificities.] Ann Inst Pasteur (Paris) 100: 490–508, 1961 (Fr)
- Fisher S, Fletcher AP, Alkjaersig N, et al: Immunoelectrophoretic characterization of plasma fibrinogen derivatives in patients with pathological plasma proteolysis. J Lab Clin Med 70: 903–922, 1967
- Allington MJ: Fibrinogen and fibrin degradation products and the clumping of staphylococci by serum. Br J Haematol 13: 550–567, 1967